Phase II High-Dose Cyclophosphamide for Multiple Sclerosis

The requested reference [9ba366aa3695e849d5f3f44921cda56071ac6218] no longer exists in our database. It has been replaced by the current reference: [f7d666f89038033535c9636c8365e10a8ae8808d]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
The purpose of this study is to determine what percentage of patients receiving high-dose Cyclophosphamide may experience a halt in the worsening of their disease or experience improvement of their disease and for how long the benefit may last.
Epistemonikos ID: 70fe43a9596d3e1b1f90c0d247b2570063ad0e64
First added on: May 04, 2024